flyExclusive Reaches Final Approval Milestone for Jet.AI Transaction, Positioning Company for Continued Growth

Stock Information for Evoke Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Evoke Pharma Inc.

UPDATE: Jet.AI Shareholders to Receive $10 Per Share in Stock and Cash as Company Signs Letter of Intent for a New $300 Million Reverse Takeover
Jet.AI Announces Letter of Intent for New Merger and related Spin-Off of Data Center Business
Jet.AI Closes Transaction with flyExclusive, Advancing Transition to a Pure-Play AI Infrastructure
Jet.AI Stockholders Approve Proposed flyExclusive Transaction
Jet.AI Stockholder Votes Exceed Majority Threshold for flyExclusive Transaction
flyExclusive Reaffirms Strategic Priorities and Provides Update on Pending Jet.AI Transaction
Jet.AI Within 2.1% (29,594 Shares) of Securing Shareholder Approval for Proposed flyExclusive Transaction; Meeting Adjourned Until July 2
Jet.AI Issues Investor Guide on Proposed flyExclusive Merger Transaction

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.